Tumor Metabolism as a Regulator of Tumor–Host Interactions in the B-Cell Lymphoma Microenvironment—Fueling Progression and Novel Brakes for Therapy

por Beielstein, Anna C., Pallasch, Christian P.
Publicado 2019

Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation

por Heisel, Sabrina M., Ketter, Ralf, Keller, Andreas, Klein, Veronika, Pallasch, Christian P., Lenhof, Hans-Peter, Meese, Eckart
Publicado 2008

A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency

por Liu, Chuan, Ding, Hongyu, Li, Xiaoxi, Pallasch, Christian P, Hong, Liya, Guo, Dianwu, Chen, Yi, Wang, Difei, Wang, Wei, Wang, Yajie, Hemann, Michael T, Jiang, Hai
Publicado 2015

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ

por Hassenrück, Floyd, Farina-Morillas, Maria, Neumann, Lars, Landini, Francesco, Blakemore, Stuart James, Rabipour, Mina, Alvarez-Idaboy, Juan Raul, Pallasch, Christian P., Hallek, Michael, Rebollido-Rios, Rocio, Krause, Günter
Publicado 2023

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2

por Barbarino, Verena, Henschke, Sinika, Blakemore, Stuart James, Izquierdo, Elena, Michalik, Michael, Nickel, Nadine, Möllenkotte, Indra, Vorholt, Daniela, Müller, Linda, Brinker, Reinhild, Fedorchenko, Oleg, Mikhael, Nelly, Seeger-Nukpezah, Tamina, Hallek, Michael, Pallasch, Christian P.
Publicado 2020

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy

por Nettersheim, Felix Sebastian, Schlüter, Johannes David, Kreuzberg, Wiebke, Mehrkens, Dennis, Grimm, Simon, Nemade, Harshal, Braumann, Simon, Hof, Alexander, Guthoff, Henning, Peters, Vera, Hoyer, Friedrich Felix, Kargapolova, Yulia, Lackmann, Jan-Wilm, Müller, Stefan, Pallasch, Christian P., Hallek, Michael, Sachinidis, Agapios, Adam, Matti, Winkels, Holger, Baldus, Stephan, Geißen, Simon, Mollenhauer, Martin
Publicado 2023

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

por Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Publicado 2023

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymph...

por Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Publicado 2023